Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
Authors:
Open Access
- 10 December 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (12) , e51256
Abstract
The ability to predict responses to chemotherapy for serous epithelial ovarian cancer (EOC) would be valuable since intrinsically chemoresistant EOC patients (persistent or recurrent disease within 6 months) gain little benefit from standard chemotherapy. The aim of this study was to screen and identify distinctive biomarkers in ascites of serous EOC associated with intrinsic chemoresistance. Protein samples from ascites of 12 chemosensitive and 7 intrinsically chemoresistant serous EOC patients were analyzed using two-dimensional fluorescence difference in gel electrophoresis (2-D DIGE) coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/TOF MS). Furthermore, the identified proteins were validated by ELISA in ascites samples from 19 chemosensitive and 9 intrinsically chemoresistant EOC patients. The number of spots detected in all 2-D DIGE gels ranged from 1523–1711 using DeCyder software analysis. Thirty-four spots were differentially expressed based on the criteria of an average ratio of more than 1.5 and a student t-test P value P = 0.001). The significantly up-regulated level of ceruloplasmin in the ascites fluid of intrinsic chemoresistant serous EOC patients suggests its potential as a prognostic biomarker for responses to chemotherapy. This finding prompts further investigation with a larger study in order to validate the clinical utility of ceruloplasmin.Keywords
This publication has 23 references indexed in Scilit:
- Calpain‐truncated CRMP‐3 and ‐4 contribute to potassium deprivation‐induced apoptosis of cerebellar granule neuronsProteomics, 2009
- Body Fluid Proteomics for Biomarker Discovery: Lessons from the Past Hold the Key to Success in the FutureJournal of Proteome Research, 2007
- Molecular profiling of platinum resistant ovarian cancerInternational Journal of Cancer, 2005
- Tumor microenvironment: What can effusions teach us?Diagnostic Cytopathology, 2005
- Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian CancersClinical Cancer Research, 2005
- The mechanism of action of platinum(IV) complexes in ovarian cancer cell linesJournal of Inorganic Biochemistry, 2004
- Malignant ascites: past, present, and futureJournal of the American College of Surgeons, 2004
- Progress and Challenges in Screening for Early Detection of Ovarian CancerMolecular & Cellular Proteomics, 2004
- Optimal sequencing in the treatment of recurrent ovarian cancerGynecologic Oncology, 2003
- The microenvironment of the tumour–host interfaceNature, 2001